Skip to main content

Want a detailed portfolio tracker?

Achieve Life Sciences (ACHV) P/E (2011 - 2026)

Achieve Life Sciences (ACHV) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Achieve Life Sciences (ACHV) P/E is -5.53. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Achieve Life Sciences (ACHV)

YearP/EChange
2026-5.53+30.78%
2025-4.23+38.94%
2024-3.05+37.12%
2023-2.22+261.11%
2022-0.61-68.69%
2021-1.96-8.55%
2020-2.15-24.26%
2019-2.84-0.89%
2018-2.86-137.28%
20177.67-99.80%
20163.79K-3520.72%
2015-110.93+568.26%
2014-16.60-60.77%
2013-42.32-74.15%
2012-163.74-59.13%
2011-400.62N/A

Comparison Achieve Life Sciences (ACHV) P/E with competitors

Achieve Life Sciences (ACHV) P/E is -5.53.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.35%
FGENFibroGen Inc0.24-104.34%
CHRSCoherus Biosciences Inc0.85-115.33%
FBIOFortress Biotech Inc0.95-117.15%
ORMPOramed Pharmaceuticals Inc1.50-127.16%
AGENAgenus Inc3.01-154.39%
INVAInnoviva Inc3.15-157.00%
VXRTVaxart Inc3.55-164.15%
CRMDCorMedix Inc3.63-165.57%
CVACCureVac N.V.4.45-180.34%
GLPGGalapagos NV4.86-187.81%
SRPTSarepta Therapeutics Inc4.88-188.23%
ABEOAbeona Therapeutics Inc5.39-197.36%
ABUSArbutus Biopharma Corp5.60-201.12%
ZVRAZevra Therapeutics Inc5.89-206.39%
SPROSpero Therapeutics Inc6.23-212.56%
CGENCompugen Ltd6.31-214.11%
RIGLRigel Pharmaceuticals6.87-224.19%
SLXNSilexion Therapeutics Corp7.30-231.85%
OMEROmeros Corporation9.26-267.32%
AUPHAurinia Pharmaceuticals Inc9.58-273.22%
PLXProtalix BioTherapeutics Inc10.89-296.82%
ACADAcadia Pharmaceuticals Inc11.73-311.96%
TBPHTheravance Biopharma Inc12.26-321.60%
ADMAAdma Biologics Inc12.42-324.42%
HRMYHarmony Biosciences Holdings Inc13.82-349.76%
SABSSAB Biotherapeutics Inc14.14-355.47%
NAGENiagen Bioscience Inc14.82-367.79%
INCYIncyte Corp15.82-385.95%
REGNRegeneron Pharmaceuticals Inc15.86-386.56%
PBYIPuma Biotechnology Inc17.32-412.93%
CPRXCatalyst Pharmaceuticals Inc17.44-415.16%
EXELExelixis Inc17.54-416.95%
TGTXTG Therapeutics Inc18.97-442.75%
MDXGMimedx Group Inc20.55-471.42%
XOMAXOMA Royalty Corp22.87-513.40%
ARGXArgen X SE24.30-539.12%
CTMXCytomX Therapeutics Inc24.82-548.58%
XOMAOXOMA Royalty Corp25.34-558.04%
HALOHalozyme Therapeutics Inc25.62-563.08%
XOMAPXOMA Royalty Corp25.67-563.92%
VRTXVertex Pharmaceuticals Inc27.99-605.93%
RPRXRoyalty Pharma plc - Class A28.69-618.45%
SLNOSoleno Therapeutics Inc29.02-624.38%
ASNDAscendis Pharma A/S30.09-643.72%
LGNDLigand Pharmaceuticals Inc - Class B37.91-785.16%
APLSApellis Pharmaceuticals Inc39.02-805.21%
BMRNBiomarin Pharmaceutical Inc42.21-862.87%
KRYSKrystal Biotech Inc45.34-919.47%
ONCBeiGene Ltd69.54-1356.77%
PHARPharming Group N.V.75.03-1455.90%
TECHBio-Techne Corp101.96-1942.64%
VCELVericel Corp109.92-2086.55%
ALNYAlnylam Pharmaceuticals Inc117.96-2231.92%
GMABGenmab140.29-2635.40%
TLXTelix Pharmaceuticals Ltd162.15-3030.50%
CORTCorcept Therapeutics Inc212.86-3946.86%